Estados financieros detallados de Karyopharm Therapeutics Inc. (KPTI): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Karyopharm Therapeutics Inc. registró ingresos de $146.1M en el último ejercicio fiscal, con un CAGR de 5 años del 6.2%.
Márgenes de los últimos 12 meses: margen bruto 95.9%, margen operativo -56.2%, margen neto -153.3%.
Al precio actual de $1.70, KPTI presenta beneficios negativos (P/E no significativo) y un ROE del 77.63%. La capitalización bursátil es de $39M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $154000 | $1.6M | $30.3M | $40.9M | $108.1M | $209.8M | $157.1M | $146.0M | $145.2M | $146.1M |
| Coste de Ventas | $86.9M | $107.3M | $161.4M | $2.4M | $2.7M | $3.4M | $5.2M | $4.9M | $6.0M | $5.9M |
| Beneficio Bruto | -$86.8M | -$105.7M | -$131.0M | $38.5M | $105.4M | $206.4M | $151.9M | $141.1M | $139.2M | $140.1M |
| I+D | $86.9M | $107.3M | $161.4M | $122.3M | $150.8M | $160.8M | $148.7M | $138.8M | $143.2M | $125.6M |
| Generales y Administrativos | $23.9M | $24.9M | $48.8M | $105.4M | $126.4M | $143.8M | $145.4M | $131.9M | $115.4M | $105.2M |
| Gastos Operativos | $110.9M | $132.1M | $210.2M | $227.8M | $277.2M | $304.7M | $294.1M | $270.6M | $258.7M | $230.8M |
| Beneficio Operativo | -$110.7M | -$130.5M | -$179.9M | -$189.3M | -$171.8M | -$98.3M | -$142.2M | -$129.5M | -$119.4M | -$90.7M |
| EBITDA | -$108.7M | -$128.2M | -$175.2M | -$182.9M | -$167.9M | -$97.0M | -$139.3M | -$118.4M | -$38.6M | -$149.9M |
| Gastos por Intereses | 0 | 0 | $2.5M | $15.6M | $27.1M | $26.0M | $25.0M | $23.8M | $37.4M | $45.8M |
| Beneficio Antes de Impuestos | -$109.4M | -$128.9M | -$178.4M | -$199.6M | -$196.0M | -$123.8M | -$164.9M | -$142.8M | -$76.4M | -$196.0M |
| Impuestos | $139000 | $63000 | $26000 | $40000 | $309000 | $268000 | $369000 | $323000 | $57000 | $43000 |
| Beneficio Neto | -$109.6M | -$129.0M | -$178.4M | -$199.6M | -$196.3M | -$124.1M | -$165.3M | -$143.1M | -$76.4M | -$196.0M |
| BPA | $-43.80 | $-42.15 | $-47.11 | $-48.32 | $-40.87 | $-24.75 | $-30.28 | $-18.79 | $-9.41 | $-17.93 |
| BPA Diluido | $-43.80 | $-42.15 | $-47.11 | $-48.32 | $-40.87 | $-24.75 | $-30.28 | $-18.79 | $-9.41 | $-17.93 |
| Acciones en Circulación (Diluidas) | $2.5M | $3.1M | $3.8M | $4.1M | $4.8M | $5.0M | $5.5M | $7.6M | $8.1M | $10.9M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $44.0M | $34.1M | $35.1M | $33.4M |
| Beneficio Bruto | $41.9M | $32.6M | $33.7M | $32.3M |
| Beneficio Operativo | -$15.2M | -$17.8M | -$26.8M | -$22.5M |
| EBITDA | -$22.6M | -$89.6M | -$9.8M | -$53.9M |
| Beneficio Neto | -$33.1M | -$102.2M | -$22.4M | -$67.0M |
| BPA | $-3.82 | $-15.16 | $-1.02 | $-2.32 |
| BPA Diluido | $-3.82 | $-5.69 | $-1.24 | $-2.32 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $49.7M | $69.0M | $118.0M | $128.9M | $85.9M | $190.5M | $135.2M | $52.2M | $62.5M | $60.5M |
| Inversiones a Corto | $79.9M | $77.5M | $210.2M | $133.1M | $163.3M | $38.2M | $142.8M | $139.2M | $46.2M | $3.2M |
| Cuentas por Cobrar | 0 | 0 | 0 | $7.9M | $12.9M | $22.5M | $47.1M | $27.0M | $30.8M | $26.2M |
| Inventario | 0 | 0 | 0 | $346000 | $2.6M | $4.1M | $4.2M | $3.0M | $4.7M | $4.0M |
| Activos Corrientes | $131.6M | $148.4M | $334.6M | $278.6M | $276.5M | $275.6M | $350.2M | $233.9M | $156.5M | $103.1M |
| Inmovilizado Material | $2.8M | $2.2M | $3.9M | $13.7M | $11.6M | $9.6M | $7.4M | $4.9M | $6.3M | $4.7M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $180.4M | $180.3M | $341.2M | $295.0M | $313.1M | $305.3M | $358.2M | $240.4M | $164.4M | $108.4M |
| Cuentas por Pagar | $4.8M | $5.7M | $4.3M | $985000 | $4.5M | $1.6M | $2.8M | $3.1M | $5.1M | $4.0M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $24.4M | $21.0M |
| Pasivos Corrientes | $16.5M | $49.5M | $46.9M | $46.4M | $60.2M | $73.7M | $65.9M | $69.5M | $92.3M | $92.1M |
| Deuda a Largo | 0 | 0 | $102.7M | $109.9M | $117.9M | $169.3M | $170.1M | $170.9M | $162.9M | $205.9M |
| Pasivos Totales | $18.1M | $50.8M | $158.0M | $245.2M | $262.5M | $385.0M | $374.8M | $376.6M | $350.4M | $401.3M |
| Reservas | -$366.1M | -$495.3M | -$673.7M | -$873.3M | -$1.07B | -$1.18B | -$1.34B | -$1.49B | -$1.56B | -$1.76B |
| Patrimonio Neto | $162.2M | $129.5M | $183.2M | $49.8M | $50.5M | -$79.7M | -$16.7M | -$136.2M | -$186.0M | -$292.9M |
| Deuda Total | 0 | 0 | $102.7M | $124.7M | $131.1M | $180.6M | $179.1M | $177.0M | $194.5M | $233.6M |
| Deuda Neta | -$129.6M | -$146.5M | -$225.5M | -$137.3M | -$118.1M | -$48.0M | -$98.9M | -$14.4M | $85.8M | $169.9M |
| Capital Circulante | $115.2M | $99.0M | $287.7M | $232.2M | $216.3M | $201.9M | $284.3M | $164.4M | $64.2M | $11.1M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $37.7M | $60.5M | $90.8M | $55.0M |
| Activos Totales | $96.2M | $108.4M | $131.4M | $111.3M |
| Pasivos Totales | $365.5M | $401.3M | $397.1M | $441.5M |
| Patrimonio Neto | -$269.3M | -$292.9M | -$265.6M | -$330.2M |
| Deuda Total | $196.4M | $233.6M | $230.9M | $215.9M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$109.6M | -$129.0M | -$178.4M | -$199.6M | -$196.3M | -$124.1M | -$165.3M | -$143.1M | -$76.4M | -$196.0M |
| Amortizaciones | $717000 | $713000 | $735000 | $974000 | $972000 | $789000 | $621000 | $530000 | $340000 | -$114000 |
| Compensación en Acciones | $22.3M | $20.4M | $17.3M | $15.3M | $24.4M | $29.8M | $35.4M | $21.7M | $18.4M | $14.1M |
| Cambio en Capital Circulante | $987000 | $33.0M | -$169000 | -$13.3M | $1.4M | -$23.2M | -$20.0M | $31.4M | -$302000 | $28.3M |
| Flujo de Caja Operativo | -$84.4M | -$73.7M | -$159.1M | -$190.8M | -$160.2M | -$107.1M | -$149.6M | -$92.7M | -$127.5M | -$75.4M |
| Inversiones (CapEx) | -$70000 | -$62000 | -$2.4M | -$206000 | -$145000 | -$5.7M | -$118000 | 0 | -$142000 | 0 |
| Adquisiciones | 0 | 0 | 0 | -$78.7M | $53.5M | $5.5M | $104.3M | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$84.5M | -$73.8M | -$161.5M | -$191.0M | -$160.4M | -$112.8M | -$149.7M | -$92.7M | -$127.6M | -$75.4M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$5.9M | -$11.8M | -$22.7M | -$24.9M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$5.9M | -$11.8M | -$22.7M | -$24.9M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $2.8M | $3.9M | $3.0M | $1.9M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +942.2% | +1790.1% | +34.8% | +164.3% | +94.1% | -25.1% | -7.0% | -0.5% | +0.6% |
| Crecimiento Beneficio Neto (anual) | | -17.7% | -38.3% | -11.9% | +1.7% | +36.8% | -33.2% | +13.4% | +46.6% | -156.5% |
| Crecimiento BPA (anual) | | +3.8% | -11.8% | -2.6% | +15.4% | +39.4% | -22.3% | +37.9% | +49.9% | -90.5% |
| Cambio en Acciones (anual) | | +22.3% | +23.7% | +9.1% | +16.3% | +4.4% | +8.8% | +39.5% | +6.7% | +34.6% |
| Crecimiento FCF (anual) | | +12.6% | -118.9% | -18.3% | +16.0% | +29.6% | -32.7% | +38.0% | -37.6% | +40.9% |
| Margen Bruto | -56353.2% | -6583.7% | -431.9% | 94.1% | 97.5% | 98.4% | 96.7% | 96.6% | 95.9% | 95.9% |
| Margen Operativo | -71903.9% | -8133.2% | -593.0% | -462.9% | -159.0% | -46.8% | -90.5% | -88.7% | -82.2% | -62.1% |
| Margen EBITDA | -70598.1% | -7988.0% | -577.4% | -447.3% | -155.3% | -46.2% | -88.7% | -81.1% | -26.6% | -102.6% |
| Margen Neto | -71153.9% | -8036.4% | -588.1% | -488.1% | -181.6% | -59.1% | -105.2% | -98.0% | -52.6% | -134.2% |
| Margen FCF | -54844.8% | -4596.8% | -532.3% | -467.1% | -148.4% | -53.8% | -95.3% | -63.5% | -87.9% | -51.6% |
| Tasa Impositiva Efectiva | -0.1% | -0.0% | -0.0% | -0.0% | -0.2% | -0.2% | -0.2% | -0.2% | -0.1% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-33.76 | $-24.11 | $-42.64 | $-46.25 | $-33.39 | $-22.50 | $-27.42 | $-12.18 | $-15.71 | $-6.89 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $2.5M | $3.1M | $3.8M | $4.1M | $4.8M | $5.0M | $5.5M | $7.6M | $8.1M | $10.9M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 77.63% |
| Rentabilidad sobre capital invertido | 376.87% |
| Rentabilidad sobre activos | -201.89% |
| Margen bruto | 95.88% |
| Margen operativo | -56.17% |
| Margen neto | -153.28% |
Salud financiera
| Deuda / Patrimonio | -0.65 |
| Ratio corriente | 0.79 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -3.22 | -3.41 | -2.98 | -5.94 | -5.67 | -3.89 | -1.68 | -0.69 | -1.08 | -0.41 |
| P/VC | 2.17 | 3.40 | 2.90 | 23.84 | 22.04 | -6.06 | -16.71 | -0.73 | -0.44 | -0.27 |
| P/V | 2287.93 | 274.25 | 17.53 | 29.01 | 10.30 | 2.30 | 1.77 | 0.68 | 0.57 | 0.55 |
| Margen Bruto | -56353.2% | -6583.7% | -431.9% | 94.1% | 97.5% | 98.4% | 96.7% | 96.6% | 95.9% | 95.9% |
| Margen Operativo | -71903.9% | -8133.2% | -593.0% | -462.9% | -159.0% | -46.8% | -90.5% | -88.7% | -82.2% | -62.1% |
| Margen Neto | -71153.9% | -8036.4% | -588.1% | -488.1% | -181.6% | -59.1% | -105.2% | -98.0% | -52.6% | -134.2% |